Primary Mucinous Adenocarcinoma of the Renal Pelvis with Elevated CEA and CA19-9

被引:17
|
作者
Ye, Yun-Lin [1 ]
Bian, Jun [1 ]
Huang, Yan-Ping [1 ]
Guo, Yan [2 ]
Li, Zhi-Xun [3 ]
Deng, Chun-Hua [1 ]
Dai, Yu-Ping [1 ]
Sun, Xiang-Zhou [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Imaging & Radiol, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510080, Guangdong, Peoples R China
关键词
Mucinous adenocarcinoma; Renal pelvis; Carcinoembryonic antigen; Carbohydrate antigen 19-9; TRANSITIONAL-CELL-CARCINOMA; CARCINOEMBRYONIC ANTIGEN; URETER;
D O I
10.1159/000329767
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Primary adenocarcinoma of the renal pelvis is rarely reported in the literature. Here we present a case of primary mucinous adenocarcinoma of the renal pelvis with elevated serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels. A 56-year-old woman was referred to our center with intermittent fever and left-sided back pain for 1 month. Computed tomography showed bilateral nephrolithiasis, mild right hydronephrosis and left pyonephrosis accompanied with ambiguous soft tissues. A radionucleorenogram showed that the glomerular filtration rate of the left and right kidney was 0 and 79 ml/min, respectively. Left nephrectomy was performed without lymph node dissection. Histopathology revealed mucinous adenocarcinoma and elevated serum CEA and CA19-9 levels were found. She died of multiorgan metastasis after 5 months. A review of the literature is also reported. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:484 / 488
页数:5
相关论文
共 50 条
  • [41] PRIMARY MUCINOUS CARCINOMA OF THE RENAL PELVIS
    SHIBAHARA, N
    OKADA, S
    ONISHI, S
    HAMADA, K
    TAKASAKI, N
    MIYAZAKI, S
    ITO, Y
    MORI, H
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1993, 189 (08) : 946 - 949
  • [42] 腹水AFP,CEA,CA19-9的联合检测
    周会祥
    洪霞
    江永青
    [J]. 实验与检验医学, 2009, 27 (04) : 378 - 378
  • [43] CEA, CA125 and CA19-9 levels in congenital gastrointestinal anomalies
    Baykal-Erkilic, A
    Erkiliç, M
    Melikoglu, M
    Aksu, A
    [J]. TURKISH JOURNAL OF PEDIATRICS, 1999, 41 (04) : 473 - 481
  • [44] Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei
    Nummela, Pirjo
    Leinonen, Hannele
    Jarvinen, Petrus
    Thiel, Alexandra
    Jarvinen, Heikki
    Lepisto, Anna
    Ristimaki, Ari
    [J]. HUMAN PATHOLOGY, 2016, 54 : 47 - 54
  • [45] PRIMARY ADENOCARCINOMA OF THE RENAL PELVIS
    KENNEDY, JS
    FIDLER, HK
    [J]. JOURNAL OF UROLOGY, 1958, 80 (04): : 208 - 213
  • [46] Quantitative serum tumor markers (CEA, CA19-9, and CA-125) are independently predictive of survival in patients with appendiceal adenocarcinoma
    Shen, J. P. Y-C.
    Yousef, A.
    Yousef, M. M. G.
    Zeineddine, M.
    Chowdhury, S.
    Knafl, M.
    Raghav, K.
    White, M. G.
    Alfaro-Munoz, K.
    Helmink, B.
    Fournier, K. F.
    Overman, M. J.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S258 - S258
  • [47] Clinical Significance of CA19-9 in the Follow-Up of Colorectal Cancer Patients with Elevated Preoperative Serum CA19-9
    Yang, Shung-Haur
    Jiang, Jeng -Kai
    Chang, Shih-Ching
    Huang, Chi-Jung
    Lin, Jen-Kou
    [J]. HEPATO-GASTROENTEROLOGY, 2013, 60 (125) : 1021 - 1027
  • [48] Elevated levels of CA19-9 and CEA are detectable in patients with type 2 diabetes and with higher frequency in patients with CVD
    Sun, YC
    Wu, TL
    Chang, PY
    Wu, JT
    [J]. CLINICAL CHEMISTRY, 2005, 51 : A59 - A59
  • [49] Mucinous adenocarcinoma of the renal pelvis associated with transitional cell carcinoma in the renal pelvis and the bladder
    Takehara, K
    Nomata, K
    Eguchi, J
    Hisamatsu, H
    Maruta, S
    Hayashi, T
    Koga, S
    Kanetake, H
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (11) : 1016 - 1018
  • [50] Elevated levels of CA19-9 and CEA are detectable in patients with type 2 diabetes and with higher frequency in patients with CVD
    Sun, YC
    Wu, TL
    Chang, PY
    Wu, JT
    [J]. CLINICAL CHEMISTRY, 2005, 51 : A59 - A60